Back to Journals

International Journal of Nanomedicine

ISSN: 1178-2013

Professor Israel (Rudi) Rubinstein

Professor Rubinstein

Dr. Israel Rubinstein is professor of medicine in the College of Medicine at the University of Illinois at Chicago. He is a member of the Section of Pulmonary, Critical Care, Allergy and Sleep Medicine at the Department of Medicine, University of Illinois at Chicago, and attending physician at the University of Illinois at Chicago Medical Center and Jesse Brown VA Medical Center, Chicago, Illinois, USA. Dr Rubinstein received his medical degree from the Hebrew University–Hadassah School of Medicine in Jerusalem. He was a medical resident in Israel, fellow in respirology at the University of Toronto and research fellow at the Cardiovascular Research Institute, University of California at San Francisco. He is board-certified in internal medicine and pulmonary disease. Dr Rubinstein holds 18 issued and pending US and international patents and has authored more than 190 peer-reviewed articles in scientific journals.

Dr Rubinstein's research interests include nanomedicine, targeted drug delivery, and bioimaging. Dr Rubinstein is the Editor-in-Chief of the International Journal of Nanomedicine and associate editor of the Journal of Biomedical Nanotechnology and member of the editorial board of several scientific journals. He is a member of the Scientific Advisory Board of the International Academy of Cardiology. Dr Rubinstein is a fellow of the American Heart Association, American College of Physicians and American College of Chest Physicians. In addition, he is a member of the American Thoracic Society, American Physiological Society, American Society for Pharmacology and Experimental Therapeutics, American Microbiology Society and the Microcirculatory Society. He is a board member and director of Advanced Life Sciences, a publicly-traded biopharmaceutical company in Woodridge, Illinois, USA, engaged in the discovery, development and commercialization of drugs in the areas of infection, cancer and respiratory disease.   

Prof. Dr. Dongwoo Khang

Prof. Dr. Khang

Dr. Dongwoo Khang is a Professor of Physiology at Gachon Medical School. His nanomedicine lab raised funds of more than $5 million for the National Research Foundation in South Korea. He has published over 80 research articles in major leading journals, including Advanced Science, ACS Nano, Biomaterials, ACS Applied Materials and Interfaces, and Nanoscale. His recent research areas are focused on translational medicine in oncology and immunology with the aid of nanomedicine.

He completed his PhD in physics and biomedical engineering at Purdue University. Then he served as a post-doctor in Brown University at the School of Engineering for two years. He worked as a faculty member in Gyeonsang National University from 2009 before joining the School of Medicine, Gachon University. He received MS and BS degrees from Seoul National University and Kyunghee University, respectively.


Prof. Dr. Anderson Oliveira Lobo

Prof. Dr. Lobo

Professor Anderson de Oliveira Lobo’s (H index: 21) degrees are in Biomedical Engineering from Universidade do Vale do Paraiba (Brazil, B.S., 2005) and in Materials Science from Technological Institute of Aeronautics (Brazil, Ph.D., 2011). Professor Lobo has graduated/supervised over 90 post-doctoral students, thesis completing B.S., M.S., and undergrads students. Professor Lobo has over 90 published papers, 2 provisional patents on the applications of nanomaterials for tissue engineering, and over 300 papers presented in conferences. Professor Lobo serves as Adhoc advisor of several international journals and Brazilian and international grant agencies.

Dr Yan Shen

Dr Shen

Dr. Yan Shen is an Associate Professor of the Department of Pharmaceutics at the China Pharmaceutical University. Her research interests focus on the design of theranostic nanoplatform for tumor treatment, developing new excipients and technologies for micro-particulate formulations as pulmonary inhaled preparations (i.e. Dry Powder Inhalations), and efficient nonviral carriers for siRNA delivery. Dr Shen has authored over 30 peer-reviewed papers, 2 patents, and 2 book chapters. Her research was rewarded with the Third Prize Award of Oncology Medicine Science and Technology in the Jiangsu Province in 2016 and the Shimazu Young Scholar Award in 2019.
She completed her Ph.D. in Pharmaceutics at China Pharmaceutical University. Then she worked as a faculty member in China Pharmaceutical University from 2010 and served as a visiting scholar at Northeastern University for one year from 2016 to 2017. She received her MS and BS degrees from the China Pharmaceutical University in 2007 and 2004, respectively.

Dr Farooq A. Shiekh

Dr Shiekh

Farooq A Shiekh is the Chair of Research and Head, Department of Biochemistry, Government Medical College (GMC) & Associated Hospital, Baramulla, India. He is a former Professor, Department of Basic Medical Sciences, Avalon University School of Medicine, Curacao, Netherlands, Antilles (2013-2016). He obtained his doctorate degree in biomedical sciences- the biochemical characterization of small particles, from one of the prestigious medical center, the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India (PhD, 2005).

In order to pursue his great interests in the field of nanoparticles, he joined at Mayo Clinic, Rochester, MN, USA, as a fellow (2007-2009) and trained as senior scientist at Faculte of de Medecine, National Center for Scientific Research (CNRS) and WHO collaborative center, La Timone Hospital, Marseille, France (2010-2012). His area of research is advancing ‘nanocarriers’ for combined targeted medicine, in order to enhance efficacy of drug delivery to reach untargetable complex tumor sites.
Dr. Shiekh also served as the consulting editor for the International Journal of Nanomedicine (2015-2019) and is associated with many other scientific organizations. He has many years of diverse teaching and research experience from renowned medical institutions of world repute.

Dr Phong A Tran

Dr Tran

Dr. Phong Tran (Senior Lecturer & Research Fellow, Science and Engineering, Queensland University of Technology, Australia, Fellow of Engineers Australia – Biomedical Engineering) received his PhD in Biophysics and Biomaterials (2010), MSc in Electrical Science and Computer Engineering (2009) from Brown University. He joined QUT in 2015 and established the Interface Science and Materials Engineering group.

Dr Tran’s research interest includes nano-biomaterials, surface modification, bio-material interfaces, local drug delivery, infection control, cancer treatment, tissue response and regeneration. He is an emerging mid-career scientist with 54 publications, 1 US patent (granted), an h-index of 15 (google scholar). As a Chief Investigator, he has been awarded research grants of more than $4.5M from funding bodies such as Australian Research Council (ARC), Queensland Government, Australian Academy of Technology and Engineering.

Dr Mian Wang

Dr Wang

Mian Wang is a postdoctoral researcher at Harvard Medical school/Brigham and Women's Hospital, as well as a research affiliate of MIT. He received his Bachelor in Biotechnology at Shandong University and his Ph. D. in Chemical Engineering at Northeastern University. His work was focused on nanomaterials for drug delivery, immunotherapy, and anti-inflammation, as well as nanotechnology for tissue engineering. Currently, he is working on nanomaterials for drug delivery and tissue regeneration. He has authored 26 peer-reviewed journal paper, 3 book chapters, 5 conference proceedings, 2 patents and he has presented his work on over 30 conferences.

Professor Lei Yang

Professor Yang

Lei Yang is the Dean and Professor in the School of Health Sciences and Biomedical Engineering at Hebei University of Technology, Tianjin, China. He received Ph.D. in Engineering (2011) and M.S. in Innovation Management and Entrepreneurship (2011) from Brown University (USA), and both M.E. and B.E. in Materials Science and Engineering from Tsinghua University (China). Before joining in Hebei University of Technology, Dr. Yang was a professor in the Orthopedic Institute at Soochow University. His research interests focus on novel biomaterials for orthopedic applications. He has authored 2 books, 3 book chapters and over 90 publications in high-profile journals including Nature Biomed Eng, Mater Today, Spine J, Adv Sci and Adv Funct Mater. His work also generated more than 17 authorized Chinese patents and 2 US patents. He is an Associate Editor of the International Journal of Nanomedicine. He is also the recipients of the Royal Academy of Engineering (UK) LIF Fellowship, International Society of Orthopaedic Surgery and Traumatology (SICOT) Research Award, Outstanding Young Scholar (2020) and Excellent Young Scholar (2016) from the National Natural Science Foundation China, the 2nd place in the China Innovation and Entrepreneurship Competition (2015), the US Fresh Face Young Scientist from Sigma Xi (2011), Student Award for Outstanding Research from the US Society For Biomaterials (2011), and Graduate Student Silver Award from the US Materials Research Society (2010). He is the senior members or members of 11 scientific and medical societies.

Professor Lijie Grace Zhang

Professor Zhang

Dr. Lijie Grace Zhang is a Professor and Associate Dean for Research in the School of Engineering and Applied Science at the George Washington University. She obtained her Ph.D. in Biomedical Engineering at Brown University. Dr. Zhang joined GW after finishing her postdoctoral training at Rice University and Harvard Medical School. She is the director of the Bioengineering Laboratory for Nanomedicine and Tissue Engineering at GW. She has received many prestigious awards including the ASME Sia Nemat-Nasser Early Career Award, NIH Director’s New Innovator Award, Society of Engineering Science Young Investigator Medal, Young Innovator in Cellular and Molecular Bioengineering, and John Haddad Young Investigator Award by the American Society for Bone and Mineral Research, etc. Her lab is focused on applying advanced 3D/4D bioprinting, nanotechnology, and stem cells for complex tissue regeneration and various disease treatments. Dr. Zhang is an American Institute for Medical and Biological Engineering (AIMBE) Fellow. She serves as the Editor-In-Chief of Biomedical Engineering Advances and Associate Editor for several high-impact international journals. Dr. Zhang was also elected to the American Society for Engineering Education (ASEE) Engineering Research Council Board of Directors and the International Society for Biofabrication (ISBF) Board of Directors.

Editorial Board

Mohammad Abdollahi, PharmD, PhD, FIAS, Professor and Head, Department of Toxicology and Pharmacology at Faculty of Pharmacy, and Head of The Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, Iran. MA achieved the 2021 Award of Clarivate Highly-Cited Scientists in Cross-Field, based on Innovated Criteria, which is equal to the Nobel Prize in the Shanghai Ranking of Universities and this update has made the TUMS to jump 100 steps up in 2022 among world universities. In 2022, MA been chosen as an Adviser to WHO to collaborate on the Horizon for Innovations in Science and Technology, and elected as a Council Member to the IAS.

Vivek Agrahari, Ph.D, Senior Scientist, CONRAD, Eastern Virginia Medical School (EVMS), Norfolk, VA, USA

Raj Bawa, MS, PhD, MD, is president of Bawa Biotech LLC, a biotech/pharma consultancy and patent law firm based in Ashburn, Virginia, USA. Trained as a microbiologist and biochemist, he is an inventor, author, entrepreneur, professor, and registered patent agent (since 2002) licensed to practice before the US Patent Office. He is currently a scientific advisor to Teva (since 2010), visiting research scholar at Albany College of Pharmacy, founding director of the American Society for Nanomedicine (established in 2008), and VP at Guanine, Inc., Rensselaer, NY. He has served as a principal investigator of various research grants, most recently as a principal investigator of a CDC grant to develop an assay for carbapenemase resistant bacteria. After earning a BSc (Honors School) in microbiology, he earned a MS (cancer biology), a PhD (biophysics/biochemistry) and an MD. In the 1990s, Dr. Bawa held various positions at the US Patent & Trademark Office, including primary examiner from 1996–2002.

Susmita Bose, Ph.D, Westinghouse Distinguished Professor, School of Mechanical and Materials Engineering, Affiliate faculty, Department of Chemistry, Affiliate faculty, Elson Floyd College of Medicine, Washington State University, Pullman, WA, USA.

Salvatore Cannistraro, Professor of Physics and Biophysics, Biophysics and Nanoscience, Scientific Director of the Biophysics and Nanoscience Centre, University of Tuscia, Viterbo, Italy

Esther Chang, Professor of Oncology, Georgetown University Medical Center, Washington, DC, USA

Young Wook Chun, Assistant Professor of Cardiovascular Medicine, Health Sciences Facility III, University of Maryland School of Medicine, Baltimore, MD, USA

Gianni Ciofani, Research Director, Smart Bio-Interfaces, Italian Institute of Technology, Pontedera (Pisa), Italy.

Mauro Comes Franchini, Department of Industrial Chemistry “Toso Montanari", University of Bologna, Bologna, Italy

Harold G. Craighead, Charles W. Lake Jr Professor of Engineering, Professor of Applied and Engineering Physics, Cornell University, Ithaca, NY, USA

Xiaohong Fang, Professor of Chemistry, Beijing National Research Center for Molecular Sciences, Key Laboratory of Molecular Nanostructures and Nanotechnology, Institute of Chemistry, Chinese Academy of Sciences, Beijing, People's Republic of China.

Robert A. Freitas Jr, Institute for Molecular Manufacturing, Palo Alto, CA, USA

Dr. Suresh Gadde, Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Canada.

Rogerio Sa Gaspar, Professor of Pharmaceutics, Faculdade de Farmácia da Universidade de Lisboa, Lisboa, Portugal

Gershon Golomb, Professor of Pharmaceutics, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel

Maling Gou, Professor, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China

Mark Gumbleton, College of Biomedical and Life Sciences, School of Pharmacy & Pharmaceutical Sciences, Cardiff University, Cardiff, UK

Justin S. Hanes, Lewis J. Ort Professor, Director, The Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Hossein Jahangirian, Department of Chemical Engineering, Engineering Center, Northeastern University, Boston, MA, USA

Ajeet Kaushik, Ph.D., Assistant Professor of Chemistry, NanoBioTech Laboratory, Health System Engineering, Department of Environmental Engineering, Florida Polytechnic University, USA.

Deok-Ho Kim, Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD, USA

Sung Yeol Kim, Associate Professor, School of Mechanical Engineering, Kyungpook National University, Dae-gu, South Korea

Wolfgang G. Kreyling (PhD), Researcher Emeritus and External Scientific Advisor, Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany. Wolfgang G. Kreyling's research interests range from aerosol sciences and nanoparticle technology to biophysics of the lungs reaching from the particle characterization to dosimetry and nanoparticle lung interactions on the level of the entire organism, cells like alveolar macrophages, and molecular compounds.

Cato T. Laurencin, University Professor; Albert and Wilda Van Dusen Distinguished Professor of Orthopaedic Surgery; Professor of Chemical and Biomolecular Engineering; Professor of Materials Science and Engineering; Professor of Biomedical Engineering; Director, The Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences; Chief Executive Officer, The Connecticut Convergence Institute for Translation in Regenerative Engineering, The University of Connecticut, Storrs, CT, USA

Chenzhong Li, Nano-Theranostics/ Bioelectronics Lab, Department of Biomedical Engineering, Florida International University, USA

Yuehe Lin, Ph.D., Professor, School of Mechanical and Materials Engineering; Adjunct Professor, Chemistry, Chemical Engineering and Bioengineering, Paul G. Allen School for Global Health, Fellow of AAAS, AIMBE, NAI, ECS, RSC, WSAS, Washington State University Pullman, WA, USA.

Feng-Huei Lin, Tenure, Institute of Biomedical Engineering, National Taiwan University, Taiwan. Director, Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes (NHRI).


Ping Ma, Scientist III, Hikma Pharmaceuticals, Bedford, OH, USA

Kasturi Muthoosamy, Associate Professor, Centre for Nanotechnology, University of Nottingham, Malaysia. 

Joseph Pergolizzi Jr, Co-Founder and Chief Operating Officer of NEMA Research, Naples, FL, USA

Xiaoyang Qi, PhD, Professor of Medicine, Division of Hematology/Oncology, Department of Internal Medicine, Director of Brain Tumor Modeling Program, Gardner Neuroscience Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Mehrdad Shadmehr, PhD, Organic Chemistry, Postdoctoral Research Associate, Department of Chemistry, University of Virginia at Charlottesville, USA.

Tolou Shokuhfar, Associate Professor, Department of Bioengineering, Director, In-situ Nanomedicine Laboratory, University of Illinois at Chicago, USA.

Eduardo Sobarzo-Sánchez, full Professor at the Medicinal and Bioinorganic Chemistry-Research Group (QMEDBIN,, Instituto de Investigación y Postgrado, Facultad de Ciencias de la Salud, Universidad Central de Chile, Chile.

Srinivas Sridhar, Director, Nanomedicine Academy, University Distinguished Professor of Physics, Bioengineering and Chemical Engineering, Northeastern University, and Lecturer, Harvard Medical School, Boston, MA, USA

Vicki Stone BSc PhD FIBiol FRSE, Professor, Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Edinburgh, UK

Yaying Sun, Ph.D. Research associate in regenerative Medicine, Orthopedics, and related Cellular Biology, Department of Sports Medicine, Huashan Hospital, Fudan University, China.

Vladimir P Torchilin, University Distinguished Professor of Pharmaceutical Sciences, Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA, USA

Dr Fabio Variola, Faculty of Engineering, Department of Mechanical Engineering, Faculty of Medicine, Department of Cellular and Molecular Medicine, University of Ottawa, Affiliate Investigator at the Children’s Hospital of Eastern Ontario (CHEO), Ontario, Canada.

Juan L. Vivero-Escoto, Associate Professor, Department of Chemistry, University of North Carolina Charlotte, Charlotte, NC, USA.

Professor Luning Wang, Laboratory of Advanced Healthcare Materials, School of Materials Science and Engineering, University of Science and Technology Beijing, No. 30, Xueyuan Road, Haidian District, Beijing, China.

You Wang, Professor, Harbin Institute of Technology, Heilongjiang, China.

Thomas J. Webster, Professor, Hebei University of Technology; Saveetha University; and UFPI, USA.

Karen L. Wooley, W. T. Doherty-Welch Chair in Chemistry, University Distinguished Professor, Director, Laboratory for Synthetic-Biologic Interactions, Department of Chemistry, Texas A&M University, College Station , TX, USA

Tohru Yamada, Associate Professor in Oncology, Department of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, Illinois, USA.

Nan Yao, Professor and Director of the PRISM Imaging and Analysis Center, Materials Science and Engineering, Princeton University, USA

Xiangdong Zhu, Ph.D., Professor, National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China.